Gershon Capital assists healthcare and life science companies achieve their business objectives through integrated reimbursement, clinical research, regulatory affairs, and marketing strategies. Through the integration of these key functional areas, we have the ability to assist our clients in the full array of activities involved in successfully moving a product from concept to commercialization. Strategic thinking and integrated operations result in approved products that rest on a foundation of strong clinical claims and data to support optimal reimbursement and impact market share.
Areas of Expertise:
•How healthcare reform may impact your company.
•How the potential reimbursement landscape can favorably impact product design, investor acceptance and commercialization.
•How to avoid the most common mistakes companies make in applying for new codes and payment rates.
•How evidence-based medicine, comparative effectiveness and value-based purchasing affect medical technology.
•How a manufacturer can obtain reimbursement for their products during clinical trials.
•How your company valuation can improve with a pricing strategy that connects the clinical or economic value of the technology.
•Understanding the financial motivations of physicians, hospitals and insurers and how this economic value story should influence every aspect of product development, from product design to valuation to commercialization.